Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Oct 21, 2024

BUY
$10.11 - $16.54 $327,311 - $535,482
32,375 New
32,375 $522,000
Q4 2023

Feb 07, 2024

BUY
$10.11 - $16.54 $327,311 - $535,482
32,375 New
32,375 $522,000
Q4 2022

Feb 13, 2023

SELL
$14.85 - $19.04 $281,674 - $361,150
-18,968 Reduced 29.67%
44,962 $736,000
Q3 2022

Nov 07, 2022

BUY
$12.38 - $20.23 $791,453 - $1.29 Million
63,930 New
63,930 $1.18 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.